News Releases

The session will highlight how BioNews’ large reach and access among rare disease patients, combined with strong community activation expertise and a patient-centric approach, accelerates trial recruitment programs. During the presentation, BioNews also will share key insights from our recent groundbreaking study, the 2024 Rare Disease Survey. BioNews will be participating in the World Orphan Drug Congress 2024 to be held April 23-25 in Boston. Marcella Debidda, PhD, president of BioNews Clinical, and Ethan Ash, senior VP of Business Development, will be presenting the session "Optimizing Patient Recruitment by Leveraging Existing Online Communities: Success Stories."  The World Orphan Drug Congress brings together industry leaders, healthcare professionals, patient advocates, and...

BioNews Inc. unveiled new branding across each of its 68 owned and operated media websites in the rare and chronic disease space. This effort includes a logo suite and visual identity for each website and establishment of BioNews as the global parent company.

BioNews announced today that Hawken Miller, a staff writer and columnist on its website Muscular Dystrophy News Today, is the recipient of a Rare Disease Journalism Fellowship by the National Press Foundation (NPF).

BioNews announced it has been named a finalist in the 2021 Medical Marketing & Media Awards (MM&M) in the category of Best Healthcare Consumer Media Brand with its entry entitled “BioNews Adopts Insider Approach to Content Development to Help People with Rare.”